Login
$NGL
$15.90 +$0.36 (2.32%) Close

$NGL SEC Filings

Filed On Filing
28 Aug 2026 Form 4: Collingsworth James M, Director

Bought 2,289 shares ($38.9K)

26 Aug 2026 Form 4: Collingsworth James M, Director

Bought 10,808 shares ($182K) · Bought 200 shares ($3.39K)

26 Aug 2026 Form 4: Raymond John T, Director

Bought 300,000 shares ($5.09M)

26 Aug 2026 Form 4: Krimbill H Michael, Director

Sold 300,000 shares ($5.1M)

25 Aug 2026 Form 4: Raymond John T, Director

Bought 1,126 shares ($18.3K) · Bought 25,500 shares ($414K)

25 Aug 2026 144
04 Aug 2026 10-Q
17 Jul 2026 Form 4: Krimbill H Michael, Director

Received 700,000 shares as a grant or award

17 Jul 2026 Form 4: Reiners Derek S, Director

Received 24,000 shares as a grant or award

17 Jul 2026 Form 4: Guderian Bryan K, Director

Received 24,000 shares as a grant or award

17 Jul 2026 Form 4: Cooper Bradley P, CFO & EVP

Received 600,000 shares as a grant or award

17 Jul 2026 Form 4: Collingsworth James M, Director

Received 24,000 shares as a grant or award

17 Jul 2026 Form 4: Coady Shawn W, Director

Received 24,000 shares as a grant or award

28 May 2026 10-K
27 Apr 2026 SCHEDULE 13G/A
12 Mar 2026 8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
10 Feb 2026 S-8
09 Feb 2026 8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
03 Feb 2026 10-Q
29 Dec 2025 Proxy statement: special meeting on February 9, 2026

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support